Corpus Intelligence IC Memo — IRON COUNTY HOSPITAL 2026-04-26 19:00 UTC
IC Memo — IRON COUNTY HOSPITAL
Investment Committee Memorandum | MO | 15 beds | Grade C | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

IRON COUNTY HOSPITAL

CCN 261336 | IRON, MO | 15 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

IRON COUNTY HOSPITAL is a 15-bed rural/critical access in IRON, MO with $17.9M in net patient revenue and a -9.8% operating margin. The hospital serves a payer mix of 48.4% Medicare, 4.6% Medicaid, and 47.0% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.8% to -2.5% (+736bps).

Net Revenue HCRIS$17.9M
Current EBITDA COMPUTED$-1.8M
Operating Margin COMPUTED-9.8%
Occupancy HCRIS33.8%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS43.6%
Distress Probability ML54.1%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
41
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -9.8% places it below the state median. Among 41 size-comparable peers (8-30 beds), the median margin is -9.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-30), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
IRON COUNTY HOSPITAL (Target)MO15$17.9M-9.8%
CASS REGIONAL MEDICAL CENTERMO25$89.9M5.4%
MISSOURI BAPTIST SULLIVAN HOSPMO25$73.4M2.7%
MOSAIC MEDICAL CENTER - MARYVIMO29$73.3M-40.5%
HEDRICK MEDICAL CENTERMO25$63.8M5.4%
COX-MONETT HOSPITALMO25$63.8M8.2%
STE. GENEVIEVE CO. MEMORIAL HOMO25$61.0M-6.8%
PERRY COUNTY MEMORIAL HOSPITALMO25$60.8M-9.3%
MERCY HOSPITAL CARTHAGEMO25$58.4M7.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$375K+210bp18mo
Cost to Collect4.5%2.5%$357K+200bp12mo
Denial Rate Reduction12.0%6.5%$354K+198bp12mo
A/R Days Reduction5200.0%3800.0%$217K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$375K
Cost to Collect
$357K
Denial Rate Reduction
$354K
A/R Days Reduction
$217K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$-1.8M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$-445K
Current Margin-9.8%
Pro Forma Margin-2.5%
WC Released (1x)$685K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.7M$1.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.7M$819K0.00x-100.0%
Bull Case9.0x11.0x$-2.4M$4.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.4M$3.9M0.00x-100.0%
Bear Case11.0x10.0x$-3.0M$-4.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.0M$-5.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 33.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 8-30 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-17.8% / P50=-9.3% / P75=-0.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.